Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.82
-0.01 (-1.30%)
At close: Aug 20, 2025, 9:40 AM

Iterum Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
13.03M 12.65M 24.13M 13.41M 4.98M 7.39M 6.07M 4.82M 13.73M 16.83M 21.09M 20.49M 9.21M 31.36M 27.45M 35.98M 36.57M 66.64M
Short-Term Investments
n/a n/a n/a 1.1M 6.74M 10.82M 17.86M 31.08M 31M 34.99M 39.75M 43.87M 59.7M 43.91M 53.94M 52.02M 57.16M 33.87M
Long-Term Investments
34K n/a n/a n/a 34K 34K 34K 34K 34K 34K -35K 34K 34K 64K -37K 64K 64K 70K
Other Long-Term Assets
19K 40K 39K 40K 763K 29K 29K 710K 2.44M 2.52M 4.21M 2.72M 3.14M 4.55M 10.16M 8.01M 9.38M 10.47M
Receivables
80K 19K 66K n/a 195K 18K 233K 170K 127K 308K n/a 795K 592K 413K 1.21M 1.03M 994K 806K
Inventory
948K 533K n/a n/a n/a n/a n/a n/a -127K -308K -1.85M n/a n/a n/a -1.21M n/a n/a n/a
Other Current Assets
n/a 19K 65K 538K n/a n/a n/a n/a 2.92M 2.42M n/a 30K 30K n/a 37K 45K 67K 30K
Total Current Assets
14.89M 13.51M 24.79M 15.85M 12.96M 19.05M 25.6M 38.53M 47.65M 54.25M 60.84M 66.65M 70.93M 76.38M 81.34M 90.21M 96.4M 104.23M
Property-Plant & Equipment
12K 18K 23K 30K 416K 508K 600K 59K 69K 62K 69K 34K 46K 62K 91K 138K 202K 387K
Goodwill & Intangibles
19.06M 19.4M 19.75M n/a n/a n/a n/a 432K 861K 1.29M 1.72M 2.15M 2.58M 3.01M 3.44M n/a n/a n/a
Total Long-Term Assets
19.12M 19.46M 19.81M 70K 1.21M 571K 663K 1.2M 3.37M 3.87M 6M 4.9M 5.76M 7.68M 10.16M 8.21M 9.65M 10.93M
Total Assets
34.01M 32.98M 44.59M 15.92M 14.17M 19.63M 26.26M 39.73M 51.02M 58.12M 66.83M 71.56M 76.69M 84.06M 91.51M 98.42M 106.05M 115.17M
Account Payables
1.19M 413K 251K 835K 822K 2.97M 5M 5.51M 3.71M 2.23M 2.77M 1.23M 787K 684K 878K 276K 1.94M 1.85M
Deferred Revenue
n/a n/a n/a n/a n/a 11K n/a -314K -348K -341K -332K -305K -292K -475K -2.5M 1.83M 1.27M 2.24M
Short-Term Debt
190K 124K 14.46M 13.71M 13.31M 12.57M n/a 314K n/a n/a n/a n/a n/a n/a 1.63M 3.24M 5.04M 6.62M
Other Current Liabilities
3.54M 201K 240K 668K 1.3M 1.11M 761K 8.41M 5.71M 4.68M 1.94M 4.7M 3.66M 6.78M 9.05M 12.48M 26.13M 33.1M
Total Current Liabilities
5.53M 3.63M 17.61M 18.7M 16.77M 17.79M 13.52M 16.4M 10.83M 7.8M 196K 7.51M 7.49M 10.08M 6.06M 17.83M 34.38M 43.81M
Long-Term Debt
32.37M 31.9M 31.07M 8.73M 8.3M 7.89M 18.96M 19.59M 31.92M 30.14M 28.47M 30.21M 23.57M 22.11M 24.9M 24.54M 20.65M 34.89M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.24M 3.44M 3.61M 3.82M 4.95M
Total Long-Term Liabilities
32.37M 31.9M 31.07M 8.73M 8.31M 7.98M 19.14M 19.9M 33.06M 31.37M 38.64M 31.5M 25.31M 25.35M 35.22M 28.14M 24.47M 39.84M
Total Liabilities
37.9M 35.53M 48.68M 27.43M 25.09M 25.77M 32.66M 36.3M 43.89M 39.16M 38.83M 39.01M 32.8M 35.43M 41.27M 45.97M 58.85M 83.65M
Total Debt
32.56M 32.02M 45.53M 22.44M 21.62M 20.55M 19.51M 19.59M 31.92M 30.14M 28.47M 30.21M 23.57M 22.11M 24.9M 27.78M 25.69M 41.51M
Common Stock
421K 357K 315K 227K 166K 165K 135K 130K 130K 128K 126K 122K 1.83M 1.83M 1.83M 1.83M 1.83M 1.79M
Retained Earnings
-497.47M -490.96M -486.07M -479.49M -473.4M -468.4M -461.3M -448.94M -445.06M -432.82M -422.93M -417.84M -388.73M -381.99M -378.49M -374.31M -378.05M -385.85M
Comprehensive Income
n/a n/a n/a 2K -1K n/a 1K 3K -26K -131K -350K n/a n/a n/a n/a -0.00 n/a 0.00
Shareholders Equity
-3.89M -2.55M -4.08M -11.51M -10.91M -6.15M -6.4M 3.43M 7.13M 18.96M 28M 32.55M 43.89M 48.63M 50.23M 52.45M 47.2M 31.52M
Total Investments
34K n/a n/a 1.1M 6.78M 10.86M 17.89M 31.08M 31M 34.99M 39.71M 43.87M 59.7M 43.91M 53.9M 52.02M 57.16M 33.87M